Concord Medical Services (NYSE:CCM) Earns Sell Rating from Analysts at StockNews.com

StockNews.com assumed coverage on shares of Concord Medical Services (NYSE:CCM) in a research report report published on Monday morning. The firm issued a sell rating on the stock.

Concord Medical Services Stock Up 4.8 %

NYSE CCM opened at $4.24 on Monday. The firm’s 50 day moving average is $4.69 and its 200-day moving average is $5.39. The company has a current ratio of 0.47, a quick ratio of 0.46 and a debt-to-equity ratio of 1.15. Concord Medical Services has a 12-month low of $3.80 and a 12-month high of $26.70.

About Concord Medical Services

Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. It operates in two segments, Network and Hospital. The company's services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services.